Lexology May 4, 2022
Mintz

The Centers for Medicare & Medicaid Services (CMS) released its Final Rule on Contract Year 2023 Policy and Technical Changes to the Medicare Advantage and Medicare Prescription Drug Benefit Programs (Final Rule) late last week. We summarized the major provisions of the CY 2023 Proposed Rule in a blog series in January, noting that the proposals sought to increase consumer protections and reduce health disparities, with a strong emphasis on policies impacting individuals who are dually eligible for Medicare and Medicaid.

This is the first post in our series on the Final Rule. Here, we discuss one of the more controversial provisions that CMS finalized and which will have immediate impacts on almost all Medicare Advantage (MA) plans: policy changes...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: CMS, Govt Agencies, Insurance, Medicare Advantage, Patient / Consumer, Provider
CMS issues flurry of Medicare fines to payers
Medicare Advantage Organizations: 7 Ways to Ensure Your Document Management Platform Offers Full Automation
Fewer Medicare Advantage Plans Are Offering Home-Based Care Services For 2025
Medicare Advantage and Part D Programs to Remain in the Enforcement Spotlight in 2025
Why aren't Medicare Advantage enrollees using supplemental benefits?

Share This Article